Takahiro Matsuo (Taka), MD

【Houston collaborative ID core curriculum #TXMedCenter】
#3 Neutropenic Fever @mdanderson.bsky.social

Definition, History, Management, and Syndromes of Neutropenic Fever, presented by Dr. Yepez!

#IDMedEd #IDFellow #IDCoreCurriculum
#UT_Infectious #BCMIDFellowship #HMH_IDfellow #MDAndersonNews

【Houston collaborative ID core curriculum #TXMedCenter】
#2 Aspergillus @mdanderson.bsky.social

Aspergillus infections in hematological malignancy presented by Dr. Kontoyiannis!

#IDMedEd #IDFellow #IDCoreCurriculum
#UT_Infectious #BCMIDFellowship #HMH_IDfellow @msgerc.bsky.social

Thank you for comment!

【ID Core Curriculum】
#1 Eye infections

The second part of our #TXMedCenter Houston collaborative ID core curriculum, hosted by @mdanderson.bsky.social has just started!

Eye infections presented by Dr. Adachi!

#IDMedEd #IDFellow #IDCoreCurriculum
#UT_Infectious #BCMIDFellowship #HMH_IDfellow

【Consequences of Delaying Surgical Intervention in Patients with Native Joint Septic Arthritis】

Excited to share our article has been published in OFID today and featured as Editor’s Choice!

Thank you for mentors and collaborators #MayoClinicINFD!

academic.oup.com/ofid/advance...

#OrthoID

【Towards shorter therapy for candidemia】Lancet ID, Aug 2025

👉Uncomplicated candidemia redefined
👉Controlled source, clinical response, and bloodstream clearance≤5 days=uncomplicated
👉Shorter courses may be safe, RCTs needed

www.thelancet.com/journals/lan...

@msgerc.bsky.social #IDMedEd #IDFellow

Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapy - Intensive Care Medicine Background Invasive candidiasis (IC) remains one of the most challenging infections in critical care, contributing significantly to morbidity, prolonged organ support, and mortality among intensive ca...

Hot off the press! IC in the ICU link.springer.com/article/10.1... #IDSky

Thank you for coming to our session today!

I truly enjoyed the discussion and learned from Q&A!

#MayoClinicINFD #OrthoID
@idweek.bsky.social #IDWeek2025

Thank you very much Jonathan!!

Thank you very much Saira!!

Just started!!

Ready for 2 oral presentations today! (same session)

Session Title: Bad to the Bone: News From BJI
Session Date: Tuesday October 21, 2025
Session Time: 10:30 AM - 11:45 AM 
Location: B401-402

#IDWeek2025 #MayoClinicINFD @idweek.bsky.social #OrthoID #SepticArthritis #NVO

Had a lot of fun at Japan night!#IDWeek2025

Our superstar Dr. Doi is the IDWeek chair!! 🇯🇵

@idweek.bsky.social

I was honored to be invited to my former workplace, St. Luke’s in Tokyo, to give a lecture on career development to the residents and fellows!

Meeting these young trainees with dreams and passion for the future was truly inspiring!

@mdanderson.bsky.social @mayoclinic.org

Thank you very much!!

Ten Practical Tips for A Successful Presentation at Infectious Diseases Clinical Case Conference Abstract. This mini review provides ten practical tips for Infectious Disease (ID) trainees presenting at ID Clinical Case Conferences. These tips, grounde

this is so good! i'd like to staple this article (and graphic) to the wall in every ID trainees' room.

these tips for ID case presentations are useful, easy to enact, and high value.

nice work @takamatsuo-id.bsky.social et al.

#meded #idsky

academic.oup.com/ofid/advance...

Thanks Jonathan! Hope this might be helpful!

【Ten Practical Tips for A Successful Presentation at Infectious Diseases Clinical Case Conference】

👉Our mini-review on ID medical education is now out!

Many thanks as well to the mentors, editors and reviewers for their valuable feedback!

academic.oup.com/ofid/advance...

#IDMedEd #IDFellow

Thanks Patrick!!

Grateful and honored to have trained at #MayoClinicINFD!

Learning from such an outstanding team!
Thank you for a remarkable year!

@mayoclinic.org
#Graduation #OrthoIDFellowship

Thank you Jonathan!!

I’m thrilled to share that our 2 musculoskeletal infections projects (NVO and septic arthritis) have been accepted for oral presentation! #MayoClinicINFD #OrthoID

Huge thanks to my mentors, collaborators, and reviewers🙏

Looking forward to seeing you in Atlanta!! @idweek.bsky.social
#IDWeek2025

Excited to share our recent article on the “B-index” in invasive pulmonary aspergillosis!

👉In addition to the D-index, blastemia is an important prognostic factor to consider!

www.journalofinfection.com/article/S016...

@msgerc.bsky.social @mdanderson.bsky.social #Aspergillosis #Bindex

Excited to share that our article is amongst the most-cited recent articles in Journal of Antimicrobial Chemotherapy! @mdanderson.bsky.social

academic.oup.com/jac/article/...

#Fusariosis @msgerc.bsky.social

Figure. (a-b): Milestones since the dawn of medical mycology. (a) Major events in supportive care of patients with hematologic cancer pertaining to mycology (b) Timeline of introduction of new antifungals.

Fungal infections in patients with hematologic malignancies in the pre-triazole era: The dawn of a new era in medical mycology

Umut Akova, Rachel Hicklen, Russell E. Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis

@cmijournal.bsky.social

www.clinicalmicrobiologyandinfection.com/article/S119...

Thank you very much #MayoClinicINFD!

Such a great time in Rochester, MN✨

【Battle of the Bots: Solving Clinical Cases in Osteoarticular Infections With Large Language Models】Mayo Clin Proc Digit Health. 2025 May

We are excited to share our recent article on the use of LLMs in osteoarticular infections!

www.mcpdigitalhealth.org/article/S294...

#MayoClinicINFD #OrthoID

Patients should be re-evaluated for response at 48-72 hours after starting therapy with integrated evaluation including clinical, lab, micro, imaging testing. Treatment should be stopped at 7 days.

Differential diagnosis for non-responding pneumonia in a hospitalized patient includes delayed recovery, infectious causes (bacterial, fungal, viral, parasitic, resistant organisms, lack of source control, etc), and non-infectious causes. This infographic provides guidance on diagnostic workup for each of these categories.

How to approach a patient hospitalized for pneumonia who is not responding to treatment?

@drandrekalil.bsky.social and colleagues
#IDSky #ICUSky

link.springer.com/article/10.1...

【Hepatic Mucormycosis】
Excited to share our latest review on hepatic mucormycosis!

👉N=40, 1990-2025
👉histopathology (73%), culture positivity was low (36%)

Big congratulations to Hazim for leading the effort!

@mdanderson.bsky.social @msgerc.bsky.social
www.mdpi.com/2309-608X/11...

After a long winter, spring has finally arrived!!😊

#MayoClinicINFD @mayoclinic.org